Task: Answer the multiple-choice question.
Query: Which compound exhibits a -7.605% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
(a) O=C(CSc1nnc(NC2CCCCC2)s1)N1CCOCC1
(b) COc1ccc(CN2CC(C(=O)NCC3CCCO3)CC2=O)cc1
(c) COc1ccc(Nc2nc3cc(C)ccc3cc2C#N)cc1
(d) CN(C)c1ccc(CNc2nc(-c3ccccc3)nn2S(C)(=O)=O)cc1
Answer: b. COc1ccc(CN2CC(C(=O)NCC3CCCO3)CC2=O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(CN2CC(C(=O)NCC3CCCO3)CC2=O)cc1
COc1ccc(CN2CC(C(=O)NCC3CCCO3)CC2=O)cc1
1-[(4-methoxyphenyl)methyl]-5-oxo-N-(oxolan-2-ylmethyl)pyrrolidine-3-carboxamide